422 related articles for article (PubMed ID: 34080327)
1. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey.
Moon JH; Koo BK; Kim W
J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):964-972. PubMed ID: 34080327
[TBL] [Abstract][Full Text] [Related]
2. Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey.
Kang S; Moon MK; Kim W; Koo BK
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1232-1241. PubMed ID: 32638541
[TBL] [Abstract][Full Text] [Related]
3. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
5. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
Hong KS; Kim MC; Ahn JH
Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
Han E; Lee YH; Kim YD; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Nam HS; Heo JH; Kim SU
Am J Gastroenterol; 2020 Apr; 115(4):584-595. PubMed ID: 32141917
[TBL] [Abstract][Full Text] [Related]
9. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
10. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
[TBL] [Abstract][Full Text] [Related]
11. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study.
Lee HJ; Lee DC; Kim CO
Front Endocrinol (Lausanne); 2021; 12():599339. PubMed ID: 33868162
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
[TBL] [Abstract][Full Text] [Related]
13. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
[TBL] [Abstract][Full Text] [Related]
14. Association of Muscle Strength with Non-Alcoholic Fatty Liver Disease in Korean Adults.
Lee SB; Kwon YJ; Jung DH; Kim JK
Int J Environ Res Public Health; 2022 Feb; 19(3):. PubMed ID: 35162699
[TBL] [Abstract][Full Text] [Related]
15. Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.
Hong J; Shin WK; Lee JW; Lee SY; Kim Y
Metab Syndr Relat Disord; 2022 May; 20(4):210-218. PubMed ID: 35100057
[No Abstract] [Full Text] [Related]
16. MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
Han E; Chun HS; Lee YH; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Lee BW; Kang ES; Cha BS; Ahn SH; Kim SU
J Gastroenterol Hepatol; 2023 Sep; 38(9):1598-1609. PubMed ID: 37321651
[TBL] [Abstract][Full Text] [Related]
17. Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study.
Zhao Q; Yin Y; Deng Y
Nutr Diabetes; 2023 Nov; 13(1):21. PubMed ID: 37968264
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.
Kim D; Wijarnpreecha K; Sandhu KK; Cholankeril G; Ahmed A
Liver Int; 2021 Aug; 41(8):1832-1840. PubMed ID: 33641244
[TBL] [Abstract][Full Text] [Related]
19. Relationship Between Protein Intake and Sarcopenia in the Elderly with Nonalcoholic Fatty Liver Disease Based on the Fourth and Fifth Korea National Health and Nutrition Examination Survey.
Hong J; Shin WK; Lee JW; Kim Y
Metab Syndr Relat Disord; 2021 Oct; 19(8):452-459. PubMed ID: 34255575
[No Abstract] [Full Text] [Related]
20. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
